Notice of Intent To Grant an Exclusive, Co-Exclusive or Partially Exclusive Patent License, 53505 [2022-18793]

Download as PDF Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices lotter on DSK11XQN23PROD with NOTICES1 • Evaluate whether the collection of information is necessary for the proper performance of the functions of the Agency, including whether the information has practical utility; • Evaluate the accuracy of MSHA’s estimate of the burden of the collection of information, including the validity of the methodology and assumptions used; • Suggest methods to enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. The information collection request will be available on https:// www.regulations.gov. MSHA cautions the commenter against providing any information in the submission that should not be publicly disclosed. Full comments, including personal information provided, will be made available on www.regulations.gov and www.reginfo.gov. The public may also examine publicly available documents at DOL-Mine Safety and Health Administration, 201 12th South, Suite 4E401, Arlington, VA 22202–5452. Sign in at the receptionist’s desk on the 4th floor via the East elevator. Before visiting MSHA in person, call 202–693–9455 to make an appointment, in keeping with the Department of Labor’s COVID–19 policy. Special health precautions may be required. Questions about the information collection requirements may be directed to the person listed in the FOR FURTHER INFORMATION section of this notice. III. Current Actions This request for collection of information contains provisions for Cleanup Program for Accumulations of Coal and Float Coal Dusts, Loose Coal, and Other Combustibles. MSHA has updated the data with respect to the number of respondents, responses, burden hours, and burden costs supporting this information collection request. Type of Review: Extension, without change, of a currently approved collection. Agency: Mine Safety and Health Administration. OMB Number: 1219–0151. Affected Public: Business or other forprofit. Number of Respondents: 195. Frequency: On occasion. VerDate Sep<11>2014 16:59 Aug 30, 2022 Jkt 256001 Number of Responses: 176. Annual Burden Hours: 243 hours. Annual Respondent or Recordkeeper Cost: $0. Comments submitted in response to this notice will be summarized and included in the request for Office of Management and Budget approval of the information collection request; they will also become a matter of public record. Song-ae Aromie Noe, Certifying Officer. [FR Doc. 2022–18776 Filed 8–30–22; 8:45 am] BILLING CODE 4510–43–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice (22–063)] Notice of Intent To Grant an Exclusive, Co-Exclusive or Partially Exclusive Patent License National Aeronautics and Space Administration. ACTION: Notice of Intent to Grant exclusive, co-exclusive or partially exclusive patent license. AGENCY: NASA hereby gives notice of its intent to grant an exclusive, coexclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below. DATES: The prospective exclusive, coexclusive or partially exclusive license may be granted unless NASA receives written objections including evidence and argument, no later than September 15, 2022 that establish that the grant of the license would not be consistent with the requirements regarding the licensing of federally owned inventions as set forth in the Bayh-Dole Act and implementing regulations. Competing applications completed and received by NASA no later than September 15, 2022 will also be treated as objections to the grant of the contemplated exclusive, coexclusive or partially exclusive license. Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act. Objections and Further Information: Written objections relating to the prospective license or requests for further information may be submitted to Agency Counsel for Intellectual Property, NASA Headquarters at Email: hq-patentoffice@mail.nasa.gov. Questions may be directed to Phone: (202) 358–3437. SUMMARY: PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 53505 NASA intends to grant an exclusive, coexclusive, or partially exclusive patent license in the United States to practice the inventions described and claimed in: U.S. Patent 10,566,089 entitled, ‘‘Nanosensor Array For Medical Diagnoses,’’ to Agscent USA Inc., having its principal place of business in Denver, CO. The fields of use may be limited. NASA has not yet made a final determination to grant the requested license and may deny the requested license even if no objections are submitted within the comment period. This notice of intent to grant an exclusive, co-exclusive or partially exclusive patent license is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). The patent rights in these inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective license will comply with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Information about other NASA inventions available for licensing can be found online at https:// technology.nasa.gov. SUPPLEMENTARY INFORMATION: Helen M. Galus, Agency Counsel for Intellectual Property. [FR Doc. 2022–18793 Filed 8–30–22; 8:45 am] BILLING CODE 7510–13–P NATIONAL SCIENCE FOUNDATION Agency Information Collection Activities: Request for Comment Regarding Common Disclosure Forms for the Biographical Sketch and Current and Pending (Other) Support National Science Foundation. Notice. AGENCY: ACTION: In accordance with the requirements of the Paperwork Reduction Act (PRA) of 1995, the National Science Foundation (NSF), on behalf of the National Science and Technology Council’s (NSTC) Research Security Subcommittee, is soliciting public comment on common disclosure forms for the Biographical Sketch and Current and Pending (Other) Support sections of a research application. An excel spreadsheet that summarizes all of the data elements that will be collected in both the Biographical Sketch and Current and Pending (Other) Support, as well as their associated attributes, also is included for public comment. The National Science Foundation has agreed to serve as steward for collection and resolution of public comments, as well SUMMARY: E:\FR\FM\31AUN1.SGM 31AUN1

Agencies

[Federal Register Volume 87, Number 168 (Wednesday, August 31, 2022)]
[Notices]
[Page 53505]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18793]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (22-063)]


Notice of Intent To Grant an Exclusive, Co-Exclusive or Partially 
Exclusive Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of Intent to Grant exclusive, co-exclusive or partially 
exclusive patent license.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice of its intent to grant an exclusive, 
co-exclusive or partially exclusive patent license to practice the 
inventions described and claimed in the patents and/or patent 
applications listed in SUPPLEMENTARY INFORMATION below.

DATES: The prospective exclusive, co-exclusive or partially exclusive 
license may be granted unless NASA receives written objections 
including evidence and argument, no later than September 15, 2022 that 
establish that the grant of the license would not be consistent with 
the requirements regarding the licensing of federally owned inventions 
as set forth in the Bayh-Dole Act and implementing regulations. 
Competing applications completed and received by NASA no later than 
September 15, 2022 will also be treated as objections to the grant of 
the contemplated exclusive, co-exclusive or partially exclusive 
license. Objections submitted in response to this notice will not be 
made available to the public for inspection and, to the extent 
permitted by law, will not be released under the Freedom of Information 
Act.
    Objections and Further Information: Written objections relating to 
the prospective license or requests for further information may be 
submitted to Agency Counsel for Intellectual Property, NASA 
Headquarters at Email: [email protected]. Questions may be 
directed to Phone: (202) 358-3437.

SUPPLEMENTARY INFORMATION: NASA intends to grant an exclusive, co-
exclusive, or partially exclusive patent license in the United States 
to practice the inventions described and claimed in: U.S. Patent 
10,566,089 entitled, ``Nanosensor Array For Medical Diagnoses,'' to 
Agscent USA Inc., having its principal place of business in Denver, CO. 
The fields of use may be limited. NASA has not yet made a final 
determination to grant the requested license and may deny the requested 
license even if no objections are submitted within the comment period.
    This notice of intent to grant an exclusive, co-exclusive or 
partially exclusive patent license is issued in accordance with 35 
U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). The patent rights in these 
inventions have been assigned to the United States of America as 
represented by the Administrator of the National Aeronautics and Space 
Administration. The prospective license will comply with the 
requirements of 35 U.S.C. 209 and 37 CFR 404.7.
    Information about other NASA inventions available for licensing can 
be found online at https://technology.nasa.gov.

Helen M. Galus,
Agency Counsel for Intellectual Property.
[FR Doc. 2022-18793 Filed 8-30-22; 8:45 am]
BILLING CODE 7510-13-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.